LIMITATIONS IN THE USE OF SERUM PROSTATE SPECIFIC ANTIGEN LEVELS TO MONITOR PATIENTS AFTER TREATMENT FOR PROSTATE CANCER-Reference-Cited by-同舟云学术

LIMITATIONS IN THE USE OF SERUM PROSTATE SPECIFIC ANTIGEN LEVELS TO MONITOR PATIENTS AFTER TREATMENT FOR PROSTATE CANCER

Published:2005-05 Issue:5 Volume:173 Page:1456-1462
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

VICINI FRANK A.¹,VARGAS CARLOS¹,ABNER ANTHONY¹,KESTIN LARRY¹,HORWITZ ERIC¹,MARTINEZ ALVARO¹

Affiliation:

1. From the Departments of Radiation Oncology, William Beaumont Hospital (FAV, CV, LK, AM), Royal Oak, Michigan, Mount Auburn Hospital (AA), Cambridge, Massachusetts, and Fox Chase Cancer Center (EH), Philadelphia, Pennsylvania

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference48 articles.

1. Practical application of biochemical failure definitions: what to do and when to do it

2. The correlation of serial prostate specific antigen measurements with clinical outcome after external beam radiation therapy of patients for prostate carcinoma

3. Validation of a treatment policy for patients with prostate specific antigen failure after three-dimensional conformal prostate radiation therapy

4. Defining biochemical cure for prostate carcinoma patients treated with external beam radiation therapy

5. Relationship between prostate volume, prostate-specific antigen nadir, and biochemical control

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Circulating Tumor DNA Assessment for Treatment Monitoring Adds Value to PSA in Metastatic Castration-Resistant Prostate Cancer;Clinical Cancer Research;2024-07-11

2. MicroFlow-Through Wool Cartridge for 3D Enrichment, Rapid Manipulation, and Label-Free Detection of Prostate Cancer Cells in Urine^*;2024 International Conference on Manipulation, Automation and Robotics at Small Scales (MARSS);2024-07-01

3. The impact of the apparent diffusion coefficient for the early prediction of the treatment response after definitive radiotherapy in prostate cancer patients;Radiotherapy and Oncology;2023-07

4. ACR Appropriateness Criteria® Post-Treatment Follow-up of Prostate Cancer: 2022 Update;Journal of the American College of Radiology;2023-05

5. Novel omics technology driving translational research in precision oncology;Advances in Genetics;2021